Prosecution Insights
Last updated: May 29, 2026

Examiner: CRUM, MARY ABOU NADER

Tech Center 1600 • Art Units: 1645 1657

This examiner grants 42% of resolved cases

Performance Statistics

41.5%
Allow Rate
-18.5% vs TC avg
127
Total Applications
+65.0%
Interview Lift
1284
Avg Prosecution Days
Based on 82 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
4.9%
§102 Novelty
50.3%
§103 Obviousness
5.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19305204 IMMUNOMODULATORY COMPOSITIONS AND METHODS Non-Final OA Innate Biologics LLC
17921788 COMPOSITION FOR IMPROVING IMMUNITY Final Rejection The Chinese University of Hong Kong
17410360 PROBIOTICS AND PROBIOTIC COMPOSITIONS HAVING MODIFIED CARBOHYDRATE METABOLISM Final Rejection UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
17971072 MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY Final Rejection The Board of Regents of the University of Oklahoma
17266717 MICROORGANISM MIXTURES, MOLECULES DERIVED THEREFROM, AND METHODS OF USE THEREOF Non-Final OA B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
17258863 SUPPORTED PLANT PLASMA MEMBRANE LIPID BILAYER ON-A-CHIP Non-Final OA Cornell University
17283265 Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection Non-Final OA N.V. Nutricia
17283287 NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE Non-Final OA N.V. Nutricia
17618927 Alpha-Amylase Variants Final Rejection Novozymes A/S
17601019 Liquid Dishwashing Detergent Compositions Non-Final OA Novozymes A/S
18051017 COMPOSITION FOR IMPROVING GUT MICROBIOTA AND METHOD FOR IMPROVING GUT MICROBIOTA WITH THE COMPOSITION THEREOF Non-Final OA TCI CO., LTD.
18569805 Compositions Comprising Microbes and Methods of Use and Making Thereof Non-Final OA Pendulum Therapeutics, Inc.
17587166 PSEUDOMONAS CHLORORAPHIS SPECIES AND ITS USE IN THE CONTROL OF DISEASES CAUSED BY BACTERIA AND FUNGI Non-Final OA UWM RESEARCH FOUNDATION, INC.
18484738 IMMUNE CHECKPOINT SUPPRESSANT Final Rejection NIHON SIZEN HAKKOH CO., LTD.
17917458 USE OF BACTERIAL STRAINS LACTOBACILLUS BREVIS, LACTOBACILLUS PLANTARUM AND/OR LACTOBACILLUS PENTOSUS IN THE REDUCTION OF AN INGESTED OR ACCUMULATED AMOUNT OF PHOSPHONATES IN THE HUMAN MICROBIOTA Non-Final OA PROBIOTICAL S.P.A.
17797891 COMPOSITION USING NOVEL LACTOBACILLUS PLANTARUM KC3 STRAIN FOR PREVENTION OR TREATMENT OF IMMUNE IMPAIRMENT, RESPIRATORY INFLAMMATORY DISEASE, ALLERGY, AND ASTHMA AND USE THEREOF Non-Final OA CKD BIO CORPORATION
17751943 METHODS TO PRODUCE DEFINED, SPHERICAL, BIO-DEGRADABLE MACROPOROUS MICROCARRIER/HYDROGELS FOR CELLULAR AGRICULTURE Final Rejection Innocent Meat GmbH
17746731 Bacillus strains improving health and performance of production animals Non-Final OA Adisseo France SAS
17646581 PROTEIN STABILIZED LIPOSOMES (PSL) AND METHODS OF MAKING THEREOF Non-Final OA Lipotope, LLC
17606145 COMPOSITION CONTAINING GLUCORAPHANIN AND USE THEREOF Final Rejection SHENZHEN FUSHAN BIOTECH CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month